Northern Trust’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.2M | Buy |
184,852
+8,038
| +5% | +$627K | ﹤0.01% | 1879 |
|
|
2025
Q4 | $14M | Sell |
176,814
-11,785
| -6% | -$1.02M | ﹤0.01% | 1902 |
|
|
2025
Q3 | $17.3M | Sell |
188,599
-874
| -0.5% | -$71.3K | ﹤0.01% | 1790 |
|
|
2025
Q2 | $12.4M | Sell |
189,473
-27,389
| -13% | -$1.78M | ﹤0.01% | 1940 |
|
|
2025
Q1 | $14.5M | Buy |
216,862
+12,517
| +6% | +$748K | ﹤0.01% | 1821 |
|
|
2024
Q4 | $11.3M | Buy |
204,345
+16,820
| +9% | +$966K | ﹤0.01% | 2056 |
|
|
2024
Q3 | $11.2M | Buy |
187,525
+19,780
| +12% | +$1.21M | ﹤0.01% | 2005 |
|
|
2024
Q2 | $10.7M | Buy |
167,745
+4,399
| +3% | +$286K | ﹤0.01% | 1958 |
|
|
2024
Q1 | $11.3M | Sell |
163,346
-3,756
| -2% | -$227K | ﹤0.01% | 1962 |
|
|
2023
Q4 | $9.21M | Sell |
167,102
-3,083
| -2% | -$170K | ﹤0.01% | 2128 |
|
|
2023
Q3 | $9.88M | Buy |
170,185
+15,633
| +10% | +$902K | ﹤0.01% | 2016 |
|
|
2023
Q2 | $8.32M | Buy |
154,552
+14,710
| +11% | +$652K | ﹤0.01% | 2195 |
|
|
2023
Q1 | $5.55M | Sell |
139,842
-1,672
| -1% | -$70.5K | ﹤0.01% | 2397 |
|
|
2022
Q4 | $5.69M | Buy |
141,514
+4,735
| +3% | +$178K | ﹤0.01% | 2406 |
|
|
2022
Q3 | $4.4M | Buy |
136,779
+845
| +0.6% | +$28.9K | ﹤0.01% | 2567 |
|
|
2022
Q2 | $4.03M | Buy |
135,934
+11,333
| +9% | +$327K | ﹤0.01% | 2642 |
|
|
2022
Q1 | $3.5M | Sell |
124,601
-1,158
| -0.9% | -$43.2K | ﹤0.01% | 2787 |
|
|
2021
Q4 | $5.79M | Buy |
125,759
+7,374
| +6% | +$317K | ﹤0.01% | 2599 |
|
|
2021
Q3 | $3.88M | Sell |
118,385
-196
| -0.2% | -$6.09K | ﹤0.01% | 2893 |
|
|
2021
Q2 | $4.16M | Buy |
118,581
+1,528
| +1% | +$52K | ﹤0.01% | 2961 |
|
|
2021
Q1 | $4.23M | Sell |
117,053
-7,639
| -6% | -$239K | ﹤0.01% | 2855 |
|
|
2020
Q4 | $3.62M | Buy |
124,692
+960
| +0.8% | +$27.5K | ﹤0.01% | 2862 |
|
|
2020
Q3 | $3.49M | Sell |
123,732
-4,371
| -3% | -$130K | ﹤0.01% | 2752 |
|
|
2020
Q2 | $4.14M | Sell |
128,103
-3,294
| -3% | -$118K | ﹤0.01% | 2630 |
|
|
2020
Q1 | $5.35M | Buy |
131,397
+2,790
| +2% | +$148K | ﹤0.01% | 2269 |
|
|
2019
Q4 | $7.93M | Sell |
128,607
-4,510
| -3% | -$299K | ﹤0.01% | 2326 |
|
|
2019
Q3 | $9.7M | Buy |
133,117
+14,076
| +12% | +$1.05M | ﹤0.01% | 2164 |
|
|
2019
Q2 | $9.79M | Buy |
119,041
+2,404
| +2% | +$171K | ﹤0.01% | 2168 |
|
|
2019
Q1 | $8.23M | Sell |
116,637
-526
| -0.4% | -$30.9K | ﹤0.01% | 2274 |
|
|
2018
Q4 | $5.27M | Sell |
117,163
-928
| -0.8% | -$48.6K | ﹤0.01% | 2468 |
|
|
2018
Q3 | $6.68M | Buy |
118,091
+1,285
| +1% | +$78.6K | ﹤0.01% | 2514 |
|
|
2018
Q2 | $7.8M | Buy |
116,806
+4,710
| +4% | +$294K | ﹤0.01% | 2430 |
|
|
2018
Q1 | $6.53M | Sell |
112,096
-1,505
| -1% | -$95.5K | ﹤0.01% | 2429 |
|
|
2017
Q4 | $7.32M | Sell |
113,601
-43
| -0% | -$2.67K | ﹤0.01% | 2378 |
|
|
2017
Q3 | $5.96M | Buy |
113,644
+739
| +0.7% | +$35.2K | ﹤0.01% | 2522 |
|
|
2017
Q2 | $5.29M | Buy |
112,905
+5,599
| +5% | +$270K | ﹤0.01% | 2601 |
|
|
2017
Q1 | $5.31M | Buy |
107,306
+4,141
| +4% | +$233K | ﹤0.01% | 2529 |
|
|
2016
Q4 | $6.25M | Buy |
103,165
+1,884
| +2% | +$115K | ﹤0.01% | 2402 |
|
|
2016
Q3 | $6.72M | Buy |
101,281
+1,681
| +2% | +$105K | ﹤0.01% | 2331 |
|
|
2016
Q2 | $5.56M | Buy |
99,600
+451
| +0.5% | +$21.9K | ﹤0.01% | 2386 |
|
|
2016
Q1 | $3.34M | Buy |
99,149
+924
| +0.9% | +$31.3K | ﹤0.01% | 2671 |
|
|
2015
Q4 | $4.43M | Buy |
98,225
+7,206
| +8% | +$310K | ﹤0.01% | 2531 |
|
|
2015
Q3 | $3.6M | Buy |
91,019
+10,644
| +13% | +$606K | ﹤0.01% | 2667 |
|
|
2015
Q2 | $4.99M | Buy |
80,375
+5,140
| +7% | +$306K | ﹤0.01% | 2518 |
|
|
2015
Q1 | $4.71M | Buy |
75,235
+1,911
| +3% | +$116K | ﹤0.01% | 2540 |
|
|
2014
Q4 | $4.13M | Sell |
73,324
-1,564
| -2% | -$69K | ﹤0.01% | 2632 |
|
|
2014
Q3 | $2.12M | Buy |
74,888
+56,738
| +313% | +$1.7M | ﹤0.01% | 3063 |
|
|
2014
Q2 | $625K | Buy |
18,150
+7,334
| +68% | +$230K | ﹤0.01% | 3540 |
|
|
2014
Q1 | $339K | Buy |
10,816
+749
| +7% | +$19.9K | ﹤0.01% | 3650 |
|
|
2013
Q4 | $202K | Buy |
+10,067
| New | +$131K | ﹤0.01% | 3715 |
|
|
2013
Q3 | – | Sell |
-6,352
| Closed | -$38K | – | 4078 |
|
|
2013
Q2 | $38K | Buy |
+6,352
| New | +$44.5K | ﹤0.01% | 3957 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
Northern Trust's ANIP Position: Q1 2026 in Review
Northern Trust increased its ANI Pharmaceuticals (ANIP) stake by 4.5% in Q1 2026, buying an estimated $627K and bringing the position to 184,852 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1879.
Northern Trust first reported a position in ANIP in Q2 2013 and has held it in 51 quarters since. The position peaked at $17.3M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.
- Northern Trust held 184,852 shares of ANI Pharmaceuticals worth $14.2M as of Q1 2026.
- Northern Trust bought 8,038 ANI Pharmaceuticals shares in Q1 2026, an estimated $627K.
- ANI Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1879 holding.
- Northern Trust first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- Northern Trust's ANI Pharmaceuticals position peaked at $17.3M in Q3 2025.
- 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.